[HTML][HTML] Estimation of kidney function in oncology: implications for anticancer drug selection and dosing

MA Casal, TD Nolin, JH Beumer - Clinical Journal of the American …, 2019 - journals.lww.com
Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …

Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing.

MA Casal, TD Nolin, JH Beumer - … Journal of the American Society of …, 2019 - europepmc.org
Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …

[PDF][PDF] for the Clinician

MA Casal, TD Nolin, JH Beumer - researchgate.net
Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …

Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing

MA Casal, TD Nolin, JH Beumer - Clinical journal of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …

[HTML][HTML] Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing

MA Casal, TD Nolin, JH Beumer - Clinical Journal of the American …, 2019 - ncbi.nlm.nih.gov
Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …

Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing.

MA Casal, TD Nolin, JH Beumer - … Journal of the American Society of …, 2019 - europepmc.org
Estimation of kidney function in patients with cancer directly affects drug dosing, agent
selection, and eligibility for clinical trials of novel agents. Overestimation of kidney function …